Recombinant Human IL-4 Protein

Cat # Size Price Quantity
63160120 μg$200
631602100 μg$610

Product Details


ApplicationBioassay
FormatLyophilized from sterile PBS, pH 7.4.
Expression HostE.coli
Research AreasCytokines, Allergy, B cell Activation, Antibody Class Switching, Th2 Polarization, Th2 cells, Infectious Diseases
Target NameIL-4,interleukin-4, B cell growth factor 1 (BCGF-1), B-cell stimulatory factor 1 (BSF-1), lymphocyte stimulatory factor 1,
SpeciesHuman
accession numberP05112-1
SourcesA DNA sequence encoding the mature form of human IL4 isoform 1 (P05112-1) (His 25-Ser 153) was expressed and purified with an initial Met.
Molecular WeightThe recombinant human IL4 consisting of 130 amino acids and migrates with an apparent molecular mass of 15.1 kDa as predicted.
Affinity TagNone
Purity≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.
Regulatory StatusRUO
Endotoxin level<0.01EU per μg protein
Protein ConcentrationLyophilized
Storage and HandlingSamples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

Background Information


Human interleukin-4 (IL-4) is a pleiotropic cytokine primarily produced by activated CD4⁺ T helper 2 (Th2) cells, basophils, and mast cells. It plays a central role in orchestrating humoral immunity by promoting B-cell proliferation, differentiation, and class switching to IgE and IgG4. IL-4 also suppresses Th1-mediated inflammatory responses, thereby skewing immune polarization toward a Th2 phenotype. Through these functions, IL-4 is critical in host defense against parasitic infections but also contributes to allergic inflammation.

Structurally, IL-4 is a small, secreted glycoprotein of approximately 15 kDa composed of a four α-helix bundle, a common motif among cytokines in the hematopoietin family. IL-4 signals through two receptor complexes: the type I receptor (IL-4Rα paired with the common γ chain) and the type II receptor (IL-4Rα with IL-13Rα1). Binding of IL-4 to these receptors activates the JAK-STAT pathway, particularly STAT6, leading to transcriptional regulation of target genes involved in immune modulation. IL-4 shares functional overlap with IL-13, which can bind the type II receptor complex.

Dysregulation of IL-4 is strongly associated with allergic diseases such as asthma, atopic dermatitis, and allergic rhinitis, where excessive IL-4 drives IgE production and eosinophilic inflammation. It is also implicated in tumor immune evasion and fibrosis in certain contexts. Therapeutically, targeting the IL-4/IL-4 receptor axis has proven effective; for example, monoclonal antibodies against IL-4Rα (blocking both IL-4 and IL-13 signaling) are widely used to treat moderate-to-severe atopic diseases. Conversely, recombinant IL-4 has been explored experimentally to enhance immune responses in cancer and vaccine settings, although its clinical use remains limited.

Data Sheets


Recombinant Human IL-4 Protein TDS


Have a product or application question? Consult our FAQs or contact us.